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Abstract: The horse reference genome assemblies, EquCab2.0 and EquCab3.0, have enabled great
advancements in the equine genomics field, from tools to novel discoveries. However, significant gaps
of knowledge regarding genome function remain, hindering the study of complex traits in horses.
In an effort to address these gaps and with inspiration from the Encyclopedia of DNA Elements
(ENCODE) project, the equine Functional Annotation of Animal Genome (FAANG) initiative was
proposed to bridge the gap between genome and gene expression, providing further insights into
functional regulation within the horse genome. Three years after launching the initiative, the equine
FAANG group has generated data from more than 400 experiments using over 50 tissues, targeting a
variety of regulatory features of the equine genome. In this review, we examine how valuable lessons
learned from the ENCODE project informed our decisions in the equine FAANG project. We report
the current state of the equine FAANG project and discuss how FAANG can serve as a template
for future expansion of functional annotation in the equine genome and be used as a reference for
studies of complex traits in horse. A well-annotated reference functional atlas will also help advance
equine genetics in the pan-genome and precision medicine era.
Keywords: FAANG; gene regulation; horse; functional annotation; transcriptome; epigenetics;
welfare; health
1. The Horse Genome
The horse reference genomes (Equcab2.0 [1] and EquCab3.0 [2]) are based on a Thor-
oughbred mare Twilight and remain the only high-quality genome assemblies for equids.
EquCab2.0 has 42,304 gaps comprising 55 Mb (2.2% of the genome) in total, with a scaffold
N50 of 46 Mb. In comparison, EquCab3.0 contains 3771 gaps comprising 9 Mb (0.34% of the
genome) with a scaffold N50 of 86 Mb. It has 99.7% mammalian Benchmarking Universal
Single-Copy Orthologs (BUSCO) (5 fragmented and 7 missing out of 4104 mammalian
universal orthologs), compared to that of 99.0% (4064 complete orthologs) in EquCab2.0 [2].
Owing to the availability of a high-quality reference genome sequence, researchers have
been able to utilize a wide variety of high-throughput tools to interrogate genetic etiologies
for various equine traits. Recently, Raudsepp et al. provided a comprehensive review
of major discoveries using combinations of recent technologies including genome-wide
association studies (GWAS), whole-genome sequencing (WGS), and RNA-seq [3].
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Using these tools, successful identification of the genetic variants responsible for
simple Mendelian traits have been identified, including a novel variant in glutamate
metabotropic receptor 6 (GRM6) associated with congenital stationary night blindness [4]
and a nonsense variant in rap guanine nucleotide exchange factor 5 (RAPGEF5) associated
with equine familial isolated hypoparathyroidism [5]. However, many GWA studies
conducted in horses have identified significant regions of association that do not contain
any known genes. In humans, it was estimated that 88% of trait/disease associated
single nucleotide polymorphisms (SNPs) identified from GWAS were either intergenic
or intronic [6]. These SNPs would later be recognized as enriched in various functional
elements [7]. Since then, numerous studies have examined different mechanisms by which
noncoding variants may affect phenotype. Variants near these significantly associated
SNPs have been found to create transcription factor (TF) binding sites [8], disrupt binding
motifs [9], or alter TF binding affinities [10,11].
These findings support the notion that many noncoding regions of DNA have important
regulatory functions that affect gene expression. With a comprehensive registry of 926,535
human regulatory elements [12], it is now common to include functional annotation in the fine
mapping of traits post-GWAS [13]. However, no such resources are available for most animal
species, including horses. To address this critical gap in knowledge, FAANG was proposed as
an effort to identify important regulatory elements in the major livestock species [14].
2. Functional Annotation of Animal Genomes
The ENCODE initiative was proposed in 2003 as an ambitious effort to “identify all
functional elements in the human genome sequence” [15]. In 2017, ENCODE concluded its
third phase, delivering an integrated set of DNA transcription, regulation, and epigenetic
modifications from a total of 7495 experiments in more than 500 cell types and tissues [12].
After almost two decades, ENCODE improved our understanding of gene regulation
and delivered a wide range of computational tools, as well as a rich deposit of well-
documented, publicly available experimental datasets [12]. Inspired by its phenomenal
success, an international group of researchers proposed a similar, coordinated effort to
systematically annotate animal genomes, providing vital resources to animal genetics
research communities, termed Functional Annotation of Animal Genomes (FAANG) [14].
As part of the FAANG initiative, the equine FAANG group has been actively working with
the larger FAANG community and ENCODE researchers to lead the annotation efforts for
the horse genome.
The first stage of the equine FAANG initiative was to generate a biobank of reference
tissues from comprehensively phenotyped animals. Burns et al. [16] and Donnelly et al. [17]
detailed the phenotyping of four selected reference animals (UCD_AH1 – UCD_AH4) and
a collection of over 80 tissues from each individual. These healthy animals were selected
from the same breed (Thoroughbred) as Twilight, the horse used to construct the equine
reference genome. When considering selection for the FAANG horses, the priority was
placed on representing healthy Thoroughbred horses. Because Twilight was selected for
the equine reference sequence based on homozygosity across the equine leukocyte antigen
(ELA) region [1], the decision was made to include three unrelated Thoroughbreds and one
(AH4) half-sibling of Twilight to achieve this goal while still aligning well with the reference
sequence. A unique aspect of this biobank is that horses were extensively phenotyped,
both antemortem by experienced veterinarians and postmortem by veterinary pathologists.
This not only ensured that there was no evidence of clinical or subclinical disease in these
animals, but it also provided insight into the cellular composition of the tissues selected for
assays. These tissues are stored at −80 ◦C in a biobank at UC Davis and are available to all
equine FAANG researchers.
Here, we briefly discuss some of the most relevant findings from ENCODE and their
implications for functionally annotating the equine genome.
Genes 2021, 12, 1707 3 of 14
3. Transcriptome
The transcriptome is the collection of all transcripts in an organism. It includes protein-
coding mRNAs as well as noncoding RNAs. During the second phase of ENCODE, 62%
of the human genome was found to be transcribed with 31% of transcribed bases located
in intergenic regions [18]. Many of these transcripts have been recognized as noncoding
RNAs with important regulatory roles [19–23]. Additionally, in any cell line, 39% of the
genome was transcribed on average. Up to 56.7% of transcriptome was detected in at least
one of fifteen studied cell lines. Interestingly, only 7% of protein-coding genes were cell-line
specific, while 53% were constitutive. In comparison, long-noncoding RNAs (lncRNAs)
appeared to contribute more to cell-line specificity, with 29% of lncRNAs detected in only
one of the fifteen studied cell lines and 10% expressed in all cell lines [18]. These results
highlighted the necessity of characterizing transcriptome in a cell-specific manner.
As part of ENCODE, GENCODE was initially founded to provide high-quality ref-
erence gene annotation for the human genome and subsequently expanded into a long-
running partnership between several groups and institutes. In its most recent release
based on GRCh38, a total of 60,649 genes have been identified in the human genome,
of which 19,955 are protein coding, with an average isoform-to-gene ratio of 3.9 [24]. It
was also demonstrated that genes tend to express many isoforms simultaneously, with a
dominant isoform comprising 30% or more of its corresponding gene expression. Isoforms
also appeared to contribute to cell type specificity, with over 75% of protein-coding genes
having different dominant isoforms in different cell lines [18].
In addition to protein-coding transcripts, the transcriptome also consists of many
noncoding RNA species, including both small and long noncoding RNAs. The functions
of these RNAs have been extensively examined and implicated in important biological
pathways [25–28]. The small noncoding RNAs present a unique opportunity to new
therapeutic approaches [29]. Extensive efforts have been put into cataloguing noncoding
RNAs in the human and mouse genome [30,31]. These efforts have further detailed the
extent of noncoding RNA regulatory network and the diversity of noncoding RNA species
and their functions.
Taken together, these findings from ENCODE demonstrated the importance of non-
coding RNAs and of alternative splicing in cell-specific expression and regulation. Both
Ensembl [32] and RefSeq [33] provide noncoding RNA and isoform annotation for Equ-
Cab3.0 by utilizing the high-quality annotation of the human genome as well as publicly
available horse RNA-seq data. RefSeq annotation for EquCab3.0 consists of 30,022 genes, of
which 21,129 are protein coding, with an average isoform-to-gene ratio of 2.6 [34]. The En-
sembl annotation of the equine genome contains 30,371 genes (20,955 protein coding) with
an average isoform-to-gene ratio of 1.9 [35]. Assuming the human and equine genomes
have a similar number of genes and consistent isoform-to-gene ratio, the current horse
gene annotation likely lacks many noncoding RNAs and alternate isoforms.
The FAANG initiative proposed RNA-seq assays for both mRNA and smRNA to
identify and quantify these transcripts in a tissue-specific manner [14]. These assays have
been performed for eight prioritized tissues (liver, lamina, heart, parietal cortex, adipose,
skeletal muscle, ovary/testis, and lung) (Table 1).
To facilitate data generation for the remaining biobanked tissues, we proposed a
unique “Adopt-A-Tissue” model for mRNA-seq. Researchers were invited to “adopt” a
tissue or tissues fitting their research interests, which meant they would cover the assay
and sequencing costs. All library preparations and sequencing were performed at the
same two locations (female samples at UC Davis, male samples at University of Nebraska-
Lincoln) to minimize variability. This approach allowed the community to contribute to
the initiative together while still being able to limit technical variations across laboratories
during library constructions [36]. Owing to this unique strategy, the equine community
has sequenced over 40 tissues, and the data have been made publicly available (Table 1).
Genes 2021, 12, 1707 4 of 14
Table 1. Overview of Available Data and Assay Details.
Project
Accession Assay Samples Tissues Instrument Library Layout
Number of
Experiments
PRJEB26698 WGS Twofemales 1
HiSeq 2500
(San Diego, CA, USA) 2 × 250 bp 2
PRJEB42407 WGS Twomales 1
NovaSeq 6000
(San Diego, CA, USA) 2 × 150 bp 2
PRJEB26787 RNA-seq Twofemales 30
HiSeq 2500
(San Diego, CA, USA) 2 × 250 bp 60
PRJEB32645 RRBS Twofemales 10
HiScanSQ










(San Diego, CA, USA) 1 × 50 bp 38
PRJEB41079 CTCF ChIP-seq Twofemales 8
HiSeq 4000
(San Diego, CA, USA) 1 × 50 bp 28
PRJEB41317 ATAC-seq pilot Twofemales 2
HiSeq 4000/NextSeq 500
(San Diego, CA, USA) 2 × 75 bp/2 × 42 bp 16
WGS: whole-genome sequencing; RNA-seq: mRNA sequencing; RRBS: reduced-representation bisulfite sequencing; Histone ChIP-seq:
chromatin immunoprecipitation using sequencing for the four major histone marks; CTCF ChIP-seq: chromatin immunoprecipitation
using sequencing for CTCF protein; ATAC-seq pilot: assay for transposase accessibility using sequencing.
More recently, long-read sequencing assays such as PacBio Isoform sequencing (Iso-
seq) have emerged as powerful tools to determine the splicing patterns of transcripts. To
address the poor isoform annotations currently available for the horse genome, Iso-seq
assays are being performed in 8 tissues (liver, lung, lamina, heart, ovary, testis, muscle,
skin, and parietal cortex) across eight PacBio Sequel 8M SMRT cells. By combining a
wide variety of assays, the equine FAANG initiative aims to deliver a comprehensively
annotated transcriptome for the horse genome.
4. Chromatin Accessibility
In mammalian cells, DNA molecules are packed by histone proteins to form nu-
cleosomes and are subsequently compacted into chromatin [37,38]. Compact chromatin
restricts access to DNA molecules by transcription factors and serves as a way to regulate
gene expression [39]. For example, nucleosomes are densely arranged in facultative and
constitutive heterochromatin while depleted in active regions such as active enhancers,
insulators, and transcribed gene bodies [40,41]. Using DNase-seq, a DNase I assay quan-
tifying susceptibility of chromatin to DNase I, Boyle et al. identified 94,925 DNase I
hypersensitive sites (DHS) covering 2.1% of the human genome [42]. It was also found that
only 13% of DHS were located within promoters, while up to 78% were in intergenic or
intronic regions. Remarkably, DHS were found in or near the transcription start sites (TSS)
of nearly all highly expressed genes. However, while DNase I hypersensitivity appeared
to be necessary for gene expression, it was not sufficient as DHS were also observed in
unexpressed genes [42]. The association between accessible chromatin and active elements
present a unique opportunity to study tissue- and cell-specific gene regulation [43–47].
Echoing their strong functional implications, accessible chromatin was also shown to be
associated with noncoding variants identified in GWAS studies of common traits. Maurano
et al. examined 5654 noncoding variants identified in the GWAS studies of 207 diseases and
447 quantitative traits and found 76.6% of these variants lie either within a DHS or in complete
linkage disequilibrium (LD) with another SNP in DHS [48]. The data further demonstrated
that many of these DHS were strongly correlated with the promoter of a distal gene target [48].
Gusev et al. analyzed the heritability of 11 common diseases and found that SNPs contained
within DHS explained up to 79% of heritability [49]. The strong association between accessible
chromatin and functional elements warranted efforts to establish a catalog of tissue-specific
DHS to facilitate discoveries of functionally relevant variants [47].
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Although DNase-seq has proven successful in identifying accessible chromatin, its
laborious protocol, slow turn-around time, and large sample size requirements severely
limit large-scale applications [50,51]. Buenrostro et al. developed Assay for Transposase-
Accessible Chromatin with high-throughput sequencing (ATAC-seq), which greatly re-
duced both time and labor costs while requiring lower nuclei input [51]. Owing to its
simple protocol and comparable output [52], ATAC-seq has been widely adopted as a
state-of-the-art method for interrogating genome-wide chromatin accessibility; further,
several variations in methodology have been developed to apply ATAC-seq to frozen
tissues [53], cryopreserved nuclei [54], or to improve sensitivity in low-input materials [55].
Using ATAC-seq on cryopreserved nuclei from eight tissues across pig, cattle, and
mouse, Halstead et al. showed a lack of conservation of sequence and accessibility in
accessible sites across evolutionary distance, with 20% shared sites between pig and cattle
and only 10% between mouse and ungulates [56]. Therefore, it is necessary to establish a
tissue-specific catalog of accessible sites specifically for the horse genome. A pilot study
was recently carried out to evaluate the suitability of frozen equine tissue derived nuclei
for ATAC-seq [57]. Following protocols established by this study, additional ATAC-seq
experiments are underway to expand this assay to eight prioritized tissues for the equine
FAANG project.
5. Histone Modifications
Histone proteins form the basic building blocks of hierarchical chromatin structures
and have been recognized to play an important role in modulating gene expression through
post-transcriptional modifications [58–61]. A nucleosome core is formed by two copies of
each of the four major types of histone proteins: H2A, H2B, H3, and H4 [62]. Since Allfrey
first suggested the potential role of histone acetylation in regulating gene expression in
1964 [58], extensive research has been carried out to understand the roles, mechanisms,
and implications of different histone modifications. Histone 3 lysine 4 monomethylation
(H3K4me1), H3K4me3, H3K27me3, and H3K27ac are among some of the most studied and
best understood modifications. Hyun et al. provided a detailed review of molecular mech-
anisms associated with histone lysine modifications and their regulatory functions [63].
Here, we briefly discuss ENCODE findings regarding histone marks and how they can be
integrated to provide a more comprehensive view of regulatory activities.
Barski et al. first comprehensively assayed histone modifications across the human
genome using high-throughput sequencing [64]. Consistent with previous studies, H3K4
methylation marks were enriched in promoter regions. A significant drop in signal between
−200 bp and +50 bp of TSS was observed for H3K4me3 with major peaks at −300 bp and
+100 bp [64]. This was consistent with observations that H3K4me3 was primarily associated
with promoter regions [65] and that nucleosomes were depleted near active TSS [40]. On
the other hand, H3K4me1 showed a distinct bimodal signal with peaks around –900 bp
and +1000 bp of TSS [64], in agreement with previous observations that H3K4me1 was
enriched in enhancer regions [66]. Similarly, H3K27me3 was observed at a higher level
around the TSS of silent genes than those around active genes, supporting correlation
between H3K27me3 and gene repression [67]. Conversely, H3K27ac was observed around
active elements and associated with higher expression level [68].
Taken together, the four histone modifications discussed in this manuscript represent
major regulatory elements and can provide valuable information regarding tissue-specific
regulatory activities in the horse genome. Using genome-wide chromatin immunopre-
cipitation sequencing (ChIP-seq) for these four marks in eight prioritized tissues in the
two female FAANG horses, Kingsley et al. reported over one million putative regulatory
sites [69]. The utility of these data were demonstrated when a 16 kB intergenic deletion
associated with an ocular condition in horses, namely distichiasis, was discovered and
FAANG ChIP-seq data showed that this region harbors a tissue specific active enhancer [70].
Undoubtedly, these data will continue to aid in the understanding of other structural vari-
ants causing or associated with disease in the horse as additional tissues are evaluated.
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Following the success of the mRNA Adopt-A-Tissue initiative, similar efforts have facil-
itated characterization of histone marks in four tissues important to equine health and
traits of economic impact (spleen, metacarpal 3, sesamoid, and skin) [71]. Furthermore,
additional Adopt-A-Tissue efforts are currently ongoing to facilitate histone ChIP-seq
assays for the remaining FAANG tissues.
6. CTCF Binding
CCCTC-binding factor (CTCF) is a well-studied zinc finger protein that serves a central
role in the formation of chromatin topology and remodeling. It was first discovered as a
repressive transcription factor in chicken for c-MYC [72] as well as LYZ [73]. It was later
shown that CTCF may also serve as an activator for the Amyloid β-Protein Precursor gene
(APP) [74]. In 1999, Bell et al. reported a CTCF binding site at the core of an insulator
element at the 5′ end of the chicken β-globin gene HBB [75]. Insulators are genomic regions
that separate genes from cis-regulatory elements [76]. This site also sits at a boundary
between active and inactive chromatin [77], a typical feature of an insulator element [78,79].
Many seemingly contradictory functions of CTCF have attracted extensive efforts
to understand the mechanisms of its multivalent roles. CTCF is highly conserved across
species [80,81] and embryonically lethal when knocked out in mice [82]. The binding
motif of CTCF consists of a ~20 bp core consensus sequence and less conserved peripheral
sequences, comprising ~50 bp [83,84]. ChIP assays targeting CTCF revealed several unique
patterns. First, CTCF binding sites were observed across the genome, with over 40% within
intergenic regions [64,83,85]. Consistent with the insulator activity of CTCF, two distinct
types of loci with opposing CTCF binding patterns were observed. Loci depleted of
CTCF binding sites tend to include clusters of related gene families and transcriptionally
coregulated genes, while loci enriched in CTCF binding sites tend to have genes with
alternative promoters [83]. Furthermore, CTCF was shown to be crucial for chromatin loop
formation at the mouse β-globin locus [86]. Similarly, Hou et al. described an alternative
loop formation by inserting a CTCF binding insulator HS5 between the β-globin locus
and its upstream locus control region [87]. Additionally, cohesin has been functionally
associated with CTCF in mediating chromatin loops [88,89]. These results suggested a
potential mechanism via which CTCF mediates regulation of chromatin conformation and
gene expression.
The introduction of Hi-C technology that enabled genome-wide interrogation of long-
range interactions [90] quickly brought about new insights into the mechanisms of CTCF
function. Refining the resolution of the Hi-C interaction maps to kilobases, Rao et al. ob-
served that the majority of chromatin loops were associated with convergent pairs of CTCF
motifs, as well as colocalizing with cohesin proteins [91]. The orientation of CTCF motifs
was also shown to determine the directionality of the CTCF mediated interactions [92].
Finally, the significance of such directionality was functionally demonstrated by inverting
CTCF sites with CRISPR to alter genome topology as well as promoter function [93].
These findings led to a proposed extrusion model [94,95], where a chromatin loop is
pulled through an extrusion complex consisting of cohesin and CTCF and is stabilized by a
CTCF dimer. This model explains the convergence of a CTCF pair surrounding a chromatin
loop, as well as the many regulatory functions of CTCF observed in early studies. More
evidence is emerging in support of this model. Based on this model, Fudenberg et al. used
simulation to reproduce topologically associated domains (TADs) and contact frequencies
observed in Hi-C studies as well as to recapitulate experimental results where TADs were
observed to spread upon depletion of CTCF binding sites [96]. Haarhuis et al. showed
that cohesin release factor WAPL could restrict chromatin loop extrusion by releasing
cohesin from DNA and that knocking out WAPL results in enlarged chromatin loops
between incorrectly orientated CTCF motifs [97]. Allahyar et al., employing a multi-contact
4C technology, showed that such enlarged loops in WAPL knockout cells are a result of
aggregated CTCF loop anchors, or a “cohesin traffic jam” [98].
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Given its central role in chromatin loop formation, CTCF binding sites can be con-
sidered an intermediate between the 1D genomic sequence and 3D chromatin topology.
Although there is no simple rule to determine the functional outcome of a disrupted CTCF
binding site, as it largely depends on its interaction with surrounding regulatory elements,
there is no doubt that a catalog of CTCF binding sites in a given cellular context can provide
valuable information when decoding the functional implications of DNA variants.
Following the practices established by the FAANG community, characterization of
CTCF binding sites using ChIP-seq is being performed on eight prioritized tissues for both
sexes. Analyses to identify both tissue and sex-specific CTCF binding and integrate all of
the FAANG ChIP-seq data into chromatin state annotations are currently underway.
7. Chromatin States
While the associations between individual histone marks and regulatory activities
are noteworthy, combinations of histone marks have proven to be more reliable in the
fine-scale predictions of regulatory elements. For example, Creyghton et al. observed that
the H3K27ac mark could distinguish active enhancers from inactive/poised enhancers,
which are both marked by H3K4me1 [68]. Bernstein et al. similarly identified a biva-
lent signal with both H3K4 methylation and H3K27 methylation, suggesting a poised
regulatory element [99]. These findings prompted hypotheses that various regulatory
functions of noncoding DNA could be explained by either additive properties [100] or
unique combinations of histone modifications [101]. New unsupervised computational
approaches were subsequently developed to classify histone modification patterns and
partition them into different chromatin states [102,103]. Ernst et al. identified 11 promoter
states, all marked by H3K4me3 and varying presence and levels of several other marks, as
well as 4 enhancer-associated states, all marked by H3K4me1 and varying frequencies of
acetylation marks [103]. These findings suggest that some histone modifications (H3K4me1,
H3K4me3) designate unique regulatory elements while other modifications (acetylation
marks including H3K27ac) enhance regulatory activity in an additive fashion.
The recognition of chromatin states and introduction of computation tools such as
ChromHMM [104] provided a way to systematically profile the regulatory landscape in any
given cellular context. Taking advantage of this development and the availability of ChIP-
seq data from the four major histone marks and CTCF, efforts to compose an integrated
tissue-specific chromatin state map are currently underway for the equine genome.
8. Unique Aspects of the Horse Genome
Centromeres are enigmatic structures because, contrary to other genetic loci, their
function is not determined by the underlying DNA sequence but depends on epigenetic
factors. The Centromere Protein A (CENP-A) is a centromere-specific variant of histone H3
that epigenetically identifies, maintains, and propagates centromere function [105]. The
characteristics of its binding domain have been elusive to investigators due to its typical as-
sociation with tandemly repeated DNA (satellite DNA). In this context, a turning point was
the discovery that the centromere of horse chromosome 11 (ECA11) was completely devoid
of satellite DNA, demonstrating for the first time that a natural mammalian centromere,
fixed in a species, can exist without satellite sequences [1]. Owing to the lack of satellite
repeats at the centromere of ECA11 and the availability of the horse reference genome,
the genomic position of the corresponding CENP-A binding domain could be precisely
identified by ChIP-on-chip with an anti-CENP-A antibody [1]. Later, several satellite-less
centromeres were identified by ChIP-seq in the donkey genome [106]. These peculiar
centromeres found in equid species represent an immature stage of “centromerization”,
being the result of centromere repositioning, which is the movement of the centromeric
function without detectable chromosomal rearrangements. This event was exceptionally
frequent during the rapid evolution of the genus Equus [107–109]. Such centromeres, be-
ing uncoupled from satellite DNA, provide a unique model for dissecting the molecular
structure of the centromere [110].
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The position of the ECA11 satellite-less centromere, identified as the CENP-A binding
domain, is not fixed in the horse population but slides within an about the 500 kb region,
giving rise to different positional alleles or “epialleles” [106,111,112]. The analysis of these
epialleles carried out on families composed by horses, donkeys, and their hybrid offspring
(mule/hinny) revealed that they are inherited as Mendelian traits, but their position can
slide in one generation [106]. Conversely, the position of the centromere is stable during
mitotic propagation of cultured cells grown for several population doublings, suggesting
that the sliding may presumably take place during meiosis or early embryogenesis [106].
The absence of satellite DNA at these centromeres also provides a unique opportunity
to understand whether some typical features of mammalian centromeres depend on the
presence of satellite DNA. In particular, it was possible to demonstrate that satellite DNA was
not necessary for segregation fidelity of the centromere [113] and was not implicated in the
suppression of meiotic recombination, which is typically exerted by the centromere [112].
The rich repository of tissues from different developmental origins available through
the FAANG project will allow us to answer other important questions on centromere
biology using the ECA11 centromere as model system. We will test whether the centromere
position is conserved during development or if it can slide during tissue differentiation. In
addition, thanks to the large amount of data regarding the functional annotation of the horse
genome, generated within the FAANG effort, we will be able to map the epigenetic marks
available through the consortium in the ECA11 centromeric region. The results will indicate
whether chromatin markers and transcriptional activity at ECA11 centromere vary across
tissues and individuals, and with respect to centromere position. Furthermore, CENP-A
has been shown to bind at TF binding sites and promoters, suggesting potential regulatory
activities [114]. Therefore, utilizing FAANG data, we will be able to identify the regulatory
activities of CENP-A and any roles centromeres may play during tissue differentiation
9. Summary and Future Perspectives
Just three years after starting the tissue and data collection for the equine FAANG
initiative, the community has completed over 400 experiments from more than 50 tissues
using a variety of assays targeting different features of the horse regulatory landscape
(Table 2). Data are being made available to the public as they are generated and evaluated
for passing quality control measures; these data have been and continue to be utilized in
unrelated research projects [5,70,115]. Integrated analysis is currently ongoing to provide
a systematic annotation of major functional elements in the horse genome available, as a
central hub hosted on UCSC genome browser to the research community.
With over 80 tissues collected from four healthy and comprehensively phenotyped
animals, we will be able to generate a map of gene expression and regulation throughout the
horse body, providing unique opportunities to investigate tissue-specific gene expression
and gene networks. However, this tissue collection presents a serious challenge for data
analyses. Heterogeneity both within tissues as a result of cell-type differentiation and
across tissues as a result of tissue infiltration or contamination during collection, can
confound analysis of tissue-specific expression and regulation. The prevalence of this issue
was recently reported by Sturm et al. [116]. To mitigate this issue, careful histological
assessment was performed during the tissue collection phase to minimize the possibility of
tissue infiltration or contamination. However, caution should be taken to assess the extent
of tissue heterogeneity during data analysis. Additionally, single-cell based technologies
have proven useful to profile cell types from complex tissues [117–120], and the adoption
of these technologies to equine FAANG data are being discussed within the community
and will likely be integrated in the next steps of the multi-phased approach of this project.
While the equine FAANG biobank represents a wide variety of tissue types, the
four horses these tissues were collected from represent only a narrow subset of the horse
population, as well as developmental stages. These horses were intentionally selected to be
of the same breed as the reference genome assembly in order to better annotate the reference
genome assembly. However, caution should be taken with interpretation and extrapolation
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of these data to other breeds or developmental stages. Regardless, this initiative will
serve as a template and reference point for the future expansion of the transcriptome and
epigenome of equids.
FAANG represents a notable international collaborative effort in the equine commu-
nity that has brought together equine researchers and practitioners from around the globe.
Most importantly, FAANG collaborators have been vocal proponents of open science and
broad data accessibility within the equine community. The growing number of publicly
available datasets is accelerating discoveries and powering large-scale analyses. Well-
annotated and carefully documented FAANG data with accompanying comprehensive
metadata will serve as a reference point for many future discoveries in horse.
Table 2. Overview of Completed Assays.
Assay Animals Tissue Types Total Experiments







Iso-seq AH1–AH4 12 48
ChIP-seq–H3K4me1 AH1–AH2 12 40AH3–AH4 8
ChIP-seq–H3K4me3 AH1–AH2 12 40AH3–AH4 8
ChIP-seq–H3K27ac AH1–AH2 12 40AH3–AH4 8
ChIP-seq–H3K27me3 AH1–AH2 12 40AH3–AH4 8
ChIP-seq–CTCF AH1–AH2 8 32AH3–AH4 8
ATAC-seq AH1–AH4 10 40
RRBS AH1–AH2 10 20
smRNA-seq AH1–AH2 48 96
Total 48 444
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